საფრანგეთის პარლამენტმა სიცოცხლის ნებაყოფლობით დასრულების შესახებ ისტორიული კანონპროექტი დაამტკიცა

2026 წლის 15 ივლისს საფრანგეთის ეროვნულმა ასამბლეამ საბოლოო მოსმენაზე მიიღო სიცოცხლის ნებაყოფლობით დასრულების (assisted dying) შესახებ კანონპროექტი, რომელიც ქვეყანაში პირველად ქმნის სამართლებრივ საფუძველს გარკვეული...

Ozempic, Wegovy and other GLP-1 agonists: What mistakes do patients make when using these medications?

GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy), liraglutide, dulaglutide, and tirzepatide, are currently considered among the most effective pharmacotherapies for the management of obesity....

UT Health San Antonio Scientists Discover First Potential Probiotic for Lupus Treatment

Researchers at the University of Texas Health Science Center at San Antonio (UT Health San Antonio) have identified a potential pathophysiological link between the...

Beyond BMI: A Novel Classification System Enables More Precise Risk Prediction for Obesity-Related Complications

Obesity and overweight represent a critical challenge to contemporary public health. Although the body mass index (BMI) has served as the standard tool for...

Crown Princess Mette-Marit of Norway has been registered on the national lung transplant waiting list due to the progression of pulmonary fibrosis

Crown Princess Mette-Marit of Norway, who has been battling pulmonary fibrosis since 2018, has been registered on the national lung transplant waiting list due...

Scientists from the Universities of Cambridge and Southampton have utilized artificial intelligence to develop the first universal vaccine

One of the primary challenges in modern immunology and epidemiology is the rapid mutation of pathogens and the static nature of existing vaccines, which...

A New Paradigm in Rheumatoid Arthritis Management: The Importance of Integrating Biopsychosocial Factors

Recent studies published in authoritative medical journals—Nature Reviews Rheumatology and The Lancet Rheumatology—examining the influence of biological, psychological, and social factors in the management...

The FDA has approved the new antiviral medication ensitrelvir (Xocova) for the post-exposure prophylaxis of COVID-19

The U.S. Food and Drug Administration (FDA) has approved the new antiviral medication ensitrelvir (Xocova), developed by the Japanese pharmaceutical company Shionogi, for the...